Read More Pharma Industry News Roche, Alnylam’s Zilebesiran meets primary endpoint in KARDIA-1 trial Breaking news in the world of hypertension treatment, Roche and Alnylam Pharmaceuticals have announced the success of their… byPallavi MadhirajuSeptember 10, 2023